Actively Recruiting

All Genders
NCT06797206

A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring

Led by Royal Brompton & Harefield NHS Foundation Trust · Updated on 2025-10-01

60

Participants Needed

1

Research Sites

150 weeks

Total Duration

On this page

Sponsors

R

Royal Brompton & Harefield NHS Foundation Trust

Lead Sponsor

C

Cystic Fibrosis Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

In this study, investigators aim to study in detail the physical (including nutritional and pulmonary) and mental health of females with cystic fibrosis (CF) planning a pregnancy, during pregnancy, and in the early parenthood period. Additionally the health of offspring in infancy and early life will be studied to understand if further screening investigations or clinical care models should be part of clinical guidelines

CONDITIONS

Official Title

A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent obtained from participant or legal guardian.
  • Under care of Royal Brompton Hospital CF Reproductive and Maternal Health Service or Adult CF Service.
  • For 'Mama': females aged 16 years or older with confirmed CF, planning pregnancy or pregnant.
  • For 'Mini': infants less than 12 months old with one biological parent diagnosed with CF.
  • For 'Midi': children aged 3 to 6 years with one biological parent diagnosed with CF.
  • Ability to attend required visits and complete investigations.
Not Eligible

You will not qualify if you...

  • For 'Mama': any significant health condition preventing protocol compliance as judged by investigator.
  • History of lung transplantation.
  • For 'Mini': legal guardian unable to provide consent.
  • Mother has significant non-CF comorbidities affecting infant outcomes as judged by investigator.
  • For 'Midi': legal guardian unable to provide consent.
  • Significant health condition known to affect lung function or imaging as judged by investigator.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Royal Brompton Hospital

London, United Kingdom

Actively Recruiting

Loading map...

Research Team

A

Amy Downes

CONTACT

I

Idan Bokobza

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here